Walker Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$795K Buy
3,132
+1
+0% +$233 0.4% 54
2026
Q1
$765K Buy
3,131
+45
+1% +$10.5K 0.41% 49
2025
Q4
$639K Sell
3,086
-85
-3% -$16.8K 0.34% 53
2025
Q3
$588K Buy
3,171
+17
+0.5% +$2.91K 0.33% 53
2025
Q2
$482K Buy
3,154
+78
+3% +$12K 0.28% 62
2025
Q1
$510K Buy
3,076
+56
+2% +$8.76K 0.31% 53
2024
Q4
$437K Buy
3,020
+17
+0.6% +$2.63K 0.27% 64
2024
Q3
$487K Buy
3,003
+14
+0.5% +$2.23K 0.3% 55
2024
Q2
$437K Buy
2,989
+156
+6% +$23.2K 0.29% 60
2024
Q1
$448K Buy
2,833
+14
+0.5% +$2.23K 0.3% 54
2023
Q4
$442K Buy
2,819
+216
+8% +$33.1K 0.32% 53
2023
Q3
$405K Buy
2,603
+12
+0.5% +$1.98K 0.36% 47
2023
Q2
$429K Buy
2,591
+12
+0.5% +$1.94K 0.35% 47
2023
Q1
$400K Buy
2,579
+12
+0.5% +$1.94K 0.35% 49
2022
Q4
$453K Buy
2,567
+111
+5% +$19.2K 0.39% 44
2022
Q3
$401K Buy
2,456
+211
+9% +$35.7K 0.36% 44
2022
Q2
$399K Sell
2,245
-90
-4% -$16K 0.36% 45
2022
Q1
$414K Buy
2,335
+10
+0.4% +$1.7K 0.33% 48
2021
Q4
$398K Buy
+2,325
New +$381K 0.35% 41

Other funds holding JNJ

Walker Asset Management's JNJ Position: Q2 2026 in Review

Walker Asset Management increased its Johnson & Johnson (JNJ) stake by 0.03% in Q2 2026, buying an estimated $233 and bringing the position to 3,132 shares worth $795K. The position accounts for 0.4% of the portfolio, ranked #54.

Walker Asset Management first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Walker Asset Management held 3,132 shares of Johnson & Johnson worth $795K as of Q2 2026.
  • Walker Asset Management bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.4% of Walker Asset Management's portfolio in Q2 2026, its #54 holding.
  • Walker Asset Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Walker Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.